FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Heribert Bohlen

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Immunotherapy

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Yama A Abassi; Heribert Bohlen; Andreas Ehlich; Ralf Kettenhofen; Eugen Kolossov; Nan Li; Wei Ouyang; Alexander Seiler; Xiaobo Wang; Manfred Watzele; Biao Xi; Xiao Xu
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.
Elke Gabriel; Jan G Hengstler; Jürgen Hescheler; Eugen Kolossov; Dirk Nierhoff; Tamara Rotshteyn; Stephanie Schievenbusch; Heribert Bohlen; Irina Drobinskaya
Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cells.
Sonja Stoelzle; Heribert Bohlen; Andrea Bruggemann; Michael George; Alison Haythornthwaite; Ralf Kettenhofen; Eugen Kolossov; Niels Fertig
Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Heribert Bohlen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yama A Abassi; Heribert Bohlen; Andreas Ehlich; Ralf Kettenhofen; Eugen Kolossov; Nan Li; Wei Ouyang; Alexander Seiler; Xiaobo Wang; Manfred Watzele; Biao Xi; Xiao Xu
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.
British journal of pharmacology 2012;165(5):1424-41.
2012: Elke Gabriel; Jan G Hengstler; Jürgen Hescheler; Eugen Kolossov; Dirk Nierhoff; Tamara Rotshteyn; Stephanie Schievenbusch; Heribert Bohlen; Irina Drobinskaya
Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cells.
PloS one 2012;7(9):e44912.
2011: Sonja Stoelzle; Heribert Bohlen; Andrea Bruggemann; Michael George; Alison Haythornthwaite; Ralf Kettenhofen; Eugen Kolossov; Niels Fertig
Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction.
Journal of biomolecular screening 2011;16(8):910-6.
2009: Silke Schwengberg; Heribert Bohlen; Bernd Fronhoff
Response to "The microEST in vitro test for embryotoxicity - a case of mistaken identity?" by Robert Combes.
Toxicology in vitro : an international journal published in association with BIBRA 2009;23(2):362-3.
2008: Irina Drobinskaya; Thomas Linn; Tomo Saric; Reinhard Bretzel; Heribert Bohlen; Jürgen Hescheler; Eugen Kolossov
Scalable selection of hepatocyte- and hepatocyte precursor-like cells from culture of differentiating transgenically modified murine embryonic stem cells.
Stem cells (Dayton, Ohio) 2008;26(9):2245-56.
2008: Ralf Kettenhofen; Heribert Bohlen
Preclinical assessment of cardiac toxicity.
Drug discovery today 2008;13(15-16):702-7.
2007: Martin Breitbach; Toktam Bostani; Wilhelm Roell; Ying Xia; Oliver Dewald; Jens Nygren; Jochen W U Fries; Klaus Tiemann; Heribert Bohlen; Jürgen Hescheler; Armin Welz; Wilhelm Bloch; Sten Eirik W Jacobsen; Bernd K Fleischmann
Potential risks of bone marrow cell transplantation into infarcted hearts.
Blood 2007;110(4):1362-9.
2006: Eugen Kolossov; Toktam Bostani; Wilhelm Roell; Martin Breitbach; Frank Pillekamp; Jens Nygren; Philipp Sasse; Olga Rubenchik; Jochen W U Fries; Daniela Wenzel; Caroline Geisen; Ying Xia; Zhongju Lu; Yaqi Duan; Ralf Kettenhofen; Stefan Jovinge; Wilhelm Bloch; Heribert Bohlen; Armin Welz; Jürgen Hescheler; Sten Eirik W Jacobsen; Bernd K Fleischmann
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.
The Journal of experimental medicine 2006;203(10):2315-27.
2005: Martin R Weihrauch; Sascha Ansén; Elke Jurkiewicz; Caroline Geisen; Zhinan Xia; Karen S Anderson; Edith Gracien; Manuel Schmidt; Burghardt Wittig; Volker Diehl; Juergen Wolf; Heribert Bohlen; Lee M Nadler
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5993-6001.
2005: Martin R Weihrauch; Oliver Manzke; Marc Beyer; Heinz Haverkamp; Volker Diehl; Heribert Bohlen; Juergen Wolf; Joachim L Schultze
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Cancer research 2005;65(13):5516-9.
2005: Eugen Kolossov; Z Lu; Irina Drobinskaya; N Gassanov; Yaqi Duan; Heinrich Sauer; Oliver Manzke; Wilhelm Bloch; Heribert Bohlen; Jürgen Hescheler; Bernd K Fleischmann
Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(6):577-9.
2005: Silke Schwengberg; Heribert Bohlen; Norbert H Kleinsasser; Kai Kehe; Mario Seiss; Udo I Walther; Reinhard Hickel; Franz-Xaver Reichl
In vitro embryotoxicity assessment with dental restorative materials.
Journal of dentistry 2005;33(1):49-55.
2004: Jürgen Hescheler; Maria Wartenberg; Daniela Wenzel; B K W Roell; Zhongju Lu; Ying Xia; F Dönmez; Frederike C Ling; Helmut Acker; Eugen Kolossov; Shohreh Kazemi; Philipp Sasse; Axel Raible; Heribert Bohlen; Wilhelm Bloch; Heinrich Sauer; Armin Welz; Bernd K Fleischmann
Implication of therapeutic cloning for organ transplantation.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2004;26 Suppl 1():S54-5; discussion S55-6.
2004: Jürgen Hescheler; Marcel Halbach; Ulrich Egert; Zhong Ju Lu; Heribert Bohlen; Bernd K Fleischmann; Michael Reppel
Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs.
Journal of electrocardiology 2004;37 Suppl():110-6.
2002: Martin R Weihrauch; Edmund Skibowski; Thomas Christian Koslowsky; Wilfried Voiss; Daniel Re; Ferdinand Kuhn-Regnier; Carolin Bannwarth; Michel Siedek; Volker Diehl; Heribert Bohlen
Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4338-43.
2002: Wilhelm Roell; Zhong Ju Lu; Wilhelm Bloch; Sharon Siedner; Klaus Tiemann; Ying Xia; Eva Stoecker; Michaela Fleischmann; Heribert Bohlen; Robert Stehle; Eugen Kolossov; Gottfried Brem; Klaus Addicks; Gabriele Pfitzer; Armin Welz; Jürgen Hescheler; Bernd K Fleischmann
Cellular cardiomyoplasty improves survival after myocardial injury.
Circulation 2002;105(20):2435-41.
2002: Martin R Weihrauch; Edmund Skibowski; Andreas Draube; Andrea Geller; Hans Tesch; Volker Diehl; Heribert Bohlen
Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies.
Clinical & experimental metastasis 2002;19(7):617-21.
2002: Joachim L Schultze; Heribert Bohlen
Influence of genomics on cancer vaccine development from guess to prediction.
Current pharmaceutical design 2002;8(19):1735-48.
2002: Martin R Weihrauch; Daniel Re; S Bischoff; Markus Dietlein; Klemens Scheidhauer; Barbara Krug; F Textoris; Sascha Ansén; Jeremy Franklin; Heribert Bohlen; Jürgen Wolf; Harald Schicha; Volker Diehl; Hans Tesch
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease.
Annals of hematology 2002;81(1):20-5.
2001: Martin R Weihrauch; Volker Diehl; Heribert Bohlen
[Artificial sweeteners--are they potentially carcinogenic?].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(11):670-5.
2001: Martin R Weihrauch; Daniel Re; Klemens Scheidhauer; Sascha Ansén; Markus Dietlein; S Bischoff; Heribert Bohlen; Jürgen Wolf; Harald Schicha; Volker Diehl; Hans Tesch
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Blood 2001;98(10):2930-4.
2001: Guenther Mathiak; Lewis F Neville; Guido Grass; SA Boehm; Thomas Luebke; T Herzmann; Koroush Kabir; R Rosendahl; Ute Schaefer; C Mueller; Heribert Bohlen; Klaus Wassermann; Arnulf H Hoelscher
Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patients.
Shock (Augusta, Ga.) 2001;15(3):176-80.
2001: Oliver Manzke; Hans Tesch; Johann Lorenzen; Volker Diehl; Heribert Bohlen
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses.
International journal of cancer. Journal international du cancer 2001;91(4):516-22.
2001: Oliver Manzke; Hans Tesch; Peter Borchmann; Jürgen Wolf; K Lackner; Axel Gossmann; Volker Diehl; Heribert Bohlen
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluation.
International journal of cancer. Journal international du cancer 2001;91(4):508-15.
2001: Oliver Manzke; O Russello; C Leenen; Volker Diehl; Heribert Bohlen; Frank Berthold
Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Medical and pediatric oncology 2001;36(1):185-9.
2000: Rüdiger Eming; Lioba Büdinger; R Riechers; O Christensen; Heribert Bohlen; R Kalish; Michael Hertl
Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay.
The British journal of dermatology 2000;143(6):1279-82.
2000: C Carstens; D K Newman; Heribert Bohlen; Angelika König; Norbert Koch
Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
International immunology 2000;12(11):1561-8.
2000: Guenther Mathiak; Guido Grass; T Herzmann; Thomas Luebke; C C Zetina; SA Boehm; Heribert Bohlen; Lewis F Neville; Arnulf H Hoelscher
Caspase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses.
British journal of pharmacology 2000;131(3):383-6.
2000: Hans Tesch; Andreas Engert; Oliver Manzke; Volker Diehl; Heribert Bohlen
Treatment of patients with malignant lymphomas with monoclonal antibodies.
Bone marrow transplantation 2000;25 Suppl 2():S50-3.
2000: S Mücke; Andreas Draube; Axel Polack; M Pawlita; Nadia Massoudi; Andrea Staratschek-Jox; Heribert Bohlen; Georg W Bornkamm; Volker Diehl; Jürgen Wolf
Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors.
International journal of cancer. Journal international du cancer 2000;86(3):301-6.
2000: HH Schäfer; Kai Hübel; Heribert Bohlen; Georg Mansmann; K Hegener; B Richarz; F Oberhäuser; Gernot Wassmer; Arnulf H Hölscher; H Pichlmaier; Volker Diehl; Andreas Engert
Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy.
Annals of hematology 2000;79(3):143-51.
2000: Heribert Bohlen; M Kessler; Michael Sextro; Volker Diehl; Hans Tesch
Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease.
Annals of hematology 2000;79(3):110-3.
2000: S Titzer; O Christensen; Oliver Manzke; Hans Tesch; Jürgen Wolf; Bertold Emmerich; C Carsten; Volker Diehl; Heribert Bohlen
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
British journal of haematology 2000;108(4):805-16.
1999: Oliver Manzke; K J Fitzgerald; Philipp Holliger; J Klock; M Span; Bernd K Fleischmann; Jürgen Hescheler; L Qinghua; K S Johnson; Volker Diehl; H R Hoogenboom; Heribert Bohlen
CD3X anti-nitrophenyl bispecific diabodies: universal immunotherapeutic tools for retargeting T cells to tumors.
International journal of cancer. Journal international du cancer 1999;82(5):700-8.
1999: Martin Kornacker; A Jox; Martina Vockerodt; Hans Tesch; Heribert Bohlen; Volker Diehl; Jürgen Wolf
Detection of a Hodgkin/Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease.
British journal of haematology 1999;106(2):528-31.
1999: Philipp Holliger; Oliver Manzke; M Span; R Hawkins; Bernd K Fleischmann; L Qinghua; J Wolf; V Diehl; O Cochet; Greg Winter; Heribert Bohlen
Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
Cancer research 1999;59(12):2909-16.
1999: C Casper; Karin Scharffetter-Kochanek; Heribert Bohlen; R P Linke; T Krieg; Nicolas Hunzelmann
Light chain multiple myeloma with peripheral leucocytosis presenting as scleroderma amyloidosum of the Alambda-type.
The British journal of dermatology 1999;140(6):1172-4.
1999: A Jox; Thomas Zander; Ralf Küppers; Johannes Irsch; H Kanzler; Martin Kornacker; Heribert Bohlen; Volker Diehl; Jürgen Wolf
Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells.
Blood 1999;93(11):3964-72.
1999: Oliver Manzke; Frank Berthold; K Huebel; Hans Tesch; Volker Diehl; Heribert Bohlen
CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.
International journal of cancer. Journal international du cancer 1999;80(5):715-22.
1999: Q H Liu; Heribert Bohlen; S Titzer; O Christensen; Volker Diehl; Jürgen Hescheler; B K Fleischmann
Expression and a role of functionally coupled P2Y receptors in human dendritic cells.
FEBS letters 1999;445(2-3):402-8.
1999: Philipp Holliger; Heribert Bohlen
Engineering antibodies for the clinic.
Cancer metastasis reviews 1999;18(4):411-9.
1998: Eugen Kolossov; Bernd K Fleischmann; Q Liu; Wilhelm Bloch; Serge Viatchenko-Karpinski; Oliver Manzke; Guan J Ji; Heribert Bohlen; Klaus Addicks; Jürgen Hescheler
Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein.
The Journal of cell biology 1998;143(7):2045-56.
1998: J Neidel; L Sova; B Schroers; F Sintermann; Oliver Manzke; Heribert Bohlen
Effects of methotrexate on normal articular cartilage in vitro and in vivo.
Annals of the rheumatic diseases 1998;57(7):414-21.
1998: Ino K Gao; C Leins; Heribert Bohlen; B Heilig; Ernst-Martin Lemmel
Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patients with rheumatoid arthritis.
Zeitschrift für Rheumatologie 1998;57(2):95-100.
1998: Hans Tesch; Heribert Bohlen; Jürgen Wolf; Andreas Engert
[Pathogenesis and therapy of Hodgkin lymphoma].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(2):82-90.
1997: Oliver Manzke; S Titzer; Hans Tesch; Volker Diehl; Heribert Bohlen
CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphoma.
Cancer immunology, immunotherapy : CII 1997;45(3-4):198-202.
1997: Oliver Manzke; Hans Tesch; Volker Diehl; Heribert Bohlen
Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatography.
Journal of immunological methods 1997;208(1):65-73.
1997: Philipp Holliger; M Wing; J D Pound; Heribert Bohlen; Greg Winter
Retargeting serum immunoglobulin with bispecific diabodies.
Nature biotechnology 1997;15(7):632-6.
1997: Heribert Bohlen; Oliver Manzke; S Titzer; Johann Lorenzen; Martin Hafner; Andreas Engert; Hinrich Abken; Jürgen Wolf; Volker Diehl; Hans Tesch
Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Cancer research 1997;57(9):1704-9.
1997: S Mũcke; Axel Polack; M Pawlita; D Zehnpfennig; Nadia Massoudi; Heribert Bohlen; W Doerfler; Georg W Bornkamm; Volker Diehl; Jürgen Wolf
Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Gene therapy 1997;4(2):82-92.
1997: Andreas Engert; Volker Diehl; Roland Schnell; A Radszuhn; M T Hatwig; S Drillich; G Schön; Heribert Bohlen; Hans Tesch; M L Hansmann; Stefan Barth; John Schindler; Victor Ghetie; Jonathan Uhr; Ellen S Vitetta
A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.
Blood 1997;89(2):403-10.
1997: Wim C Vooijs; Henny G Otten; M van Vliet; Anette J G van-Dijk; Roel A de Weger; Mark de Boer; Heribert Bohlen; Andrea Bolognesi; Letizia Polito; Gijsbert C De Gast
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.
British journal of cancer 1997;76(9):1163-9.
1996: Heribert Bohlen; K Thielemanns; Hans Tesch; Andreas Engert; H J Wolf; B van Camp; J Urbain; Volker Diehl
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
Cytokines and molecular therapy 1996;2(4):231-8.
1996: Alexander Klimka; Stefan Barth; S Drillich; W Wels; J van Snick; J C Renauld; H Tesch; Heribert Bohlen; Volker Diehl; Andreas Engert
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines.
Cytokines and molecular therapy 1996;2(3):139-46.
1996: Jürgen Wolf; U Kapp; Heribert Bohlen; Martin Kornacker; C Schoch; B Stahl; S Mücke; C von Kalle; C Fonatsch; H E Schaefer; Martin-Leo Hansmann; Volker Diehl
Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.
Blood 1996;87(8):3418-28.
1996: U Winkler; Heribert Bohlen; V Schirrmacher; G Schlimok; Dimitris Voliotis; M Brach; N Niederle; Hans Tesch; Volker Diehl; Andreas Engert
[Immunotherapy of hemato-oncologic diseases].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(4):226-33.
1996: F Westermann; Martin Hafner; B Haier; Heribert Bohlen; Andreas Engert; M Zuehlsdorf; Volker Diehl; Hans Tesch
Interleukin 10 inhibits cytokine production of human AML cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):397-404.
1996: J Wolf; Heribert Bohlen; Volker Diehl
Report on the workshop biology of the Third International Symposium on Hodgkin's Lymphoma in Cologne 1995.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():45-7.
1995: Andreas Engert; C Gottstein; Heribert Bohlen; U Winkler; G Schön; O Manske; Roland Schnell; Volker Diehl; P Thorpe
Cocktails of ricin A-chain immunotoxins against different antigens on Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice.
International journal of cancer. Journal international du cancer 1995;63(2):304-9.
1995: Roland Schnell; C Linnartz; A A Katouzi; G Schön; Heribert Bohlen; O Horn-Lohrens; R M Parwaresch; Hans Lange; Volker Diehl; Hilmar Lemke
Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.
International journal of cancer. Journal international du cancer 1995;63(2):238-44.
1995: D T Nguyen; L W Diamond; M Schwonzen; Heribert Bohlen; Volker Diehl
Chronic lymphocytic leukemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphoma.
Leukemia & lymphoma 1995;18(1-2):179-84.
1995: M Gorschlüter; Heribert Bohlen; Dirk Hasenclever; Volker Diehl; Hans Tesch
Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(5):477-82.
1995: Jürgen Wolf; Andreas Draube; Heribert Bohlen; A Jox; S Mücke; M Pawlita; P Möller; Volker Diehl
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
International journal of cancer. Journal international du cancer 1995;60(4):527-33.
1995: Martin Hafner; Cornelia Platzer; A von Knethen; H Straub; Heribert Bohlen; M Hafner; Hans Tesch
Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
Cytokine 1995;7(1):1-7.
1994: D Spickermann; Angela Gause; Michael Pfreundschuh; A K Von Kalle; Heribert Bohlen; Volker Diehl
Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemias.
Leukemia & lymphoma 1994;16(1-2):89-96.
1994: Heribert Bohlen; Oliver Manzke; Andreas Engert; M Hertel; R Hippler-Altenburg; Volker Diehl; Hans Tesch
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation.
Journal of immunological methods 1994;173(1):55-62.
1994: V Diehl; Heribert Bohlen; J Wolf
CD30: cytokine-receptor, differentiation marker or a target molecule for specific immune response?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(4):300-2.
1994: S Schmitz; Hans Tesch; Heribert Bohlen; Andreas Engert; Volker Diehl
[Chronic fatigue syndrome].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(3):154-9.
1994: U Winkler; C Gottstein; G Schön; U Kapp; Jürgen Wolf; Martin-Leo Hansmann; Heribert Bohlen; P Thorpe; Volker Diehl; Andreas Engert
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins.
Blood 1994;83(2):466-75.
1994: C Gottstein; U Winkler; Heribert Bohlen; Volker Diehl; Andreas Engert
Immunotoxins: is there a clinical value?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():97-103.
1993: Michael Hertl; Heribert Bohlen; Frank K Jugert; C Boecker; R Knaup; Hans F Merk
Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics.
The Journal of investigative dermatology 1993;101(6):794-9.
1993: Heribert Bohlen; T Hopff; Oliver Manzke; Andreas Engert; Martin Hafner; PD Wickramanayake; Volker Diehl; Hans Tesch
Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
Blood 1993;82(6):1803-12.
1993: Heribert Bohlen; Oliver Manzke; B Patel; G Moldenhauer; B Dörken; V von Fliedner; Volker Diehl; Hans Tesch
Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
Cancer research 1993;53(18):4310-4.
1993: C Pohl; R Denfeld; C Renner; W Jung; Heribert Bohlen; Ugur Sahin; Andreas Hombach; R van Lier; M Schwonzen; Volker Diehl
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1993;54(5):820-7.
1993: M Hertl; Heribert Bohlen; Hans F Merk
Efficacy of cyclophosphamide in toxic epidermal necrolysis.
Journal of the American Academy of Dermatology 1993;28(3):511.
1992: M Hertl; Hans F Merk; Heribert Bohlen
T-cell subsets in drug-induced toxic epidermal necrolysis.
Archives of dermatology 1992;128(2):272.